Diabetes is a risky metabolic chronic sickness that threatens the lives and health of individuals, families, and communities
everywhere. Management of diabetes and related metabolic syndrome (MS) relies heavily on diet. There are reports of
folk plants showing varying levels of antihyperglycemic activity. Phyllanthus emblica Linn (syn. Emblica officinalis)
(often referred to Emblic, Indian gooseberry, or amla) is a perennial tree in the Euphorbiaceae family. Due to the
high concentration of phenolic compounds, Emblic fruit may be considered a plant source of natural antioxidants.
Numerous studies have demonstrated Emblic fruit’s benefits on humans and animals that are antihyperglycemic, anti-inflammatory, antihyperlipidemic, antibacterial, analgesic and antipyretic, adaptogenic, hepatoprotective, anticancer,
antiulcerogenic, and antioxidant. This review provided an overview of the published scientific studies (experimental and
clinical) that documented the potential antidiabetic and antihyperlipidemic benefits associated with consuming Emblic
fruits. In addition, the possible activity regarding related metabolic syndrome and diabetes complications was assessed.
Key words: Diabetes, hyperlipidemia, metabolic syndrome, Emblic fruit
|
